Neurology Alert
RSSArticles
-
Costs and Consequences of Chronic Pain Among U.S. Adults
Chronic and disabling pain is a common and serious cause of morbidity among U.S. adults.
-
Quality of Life After Focused Ultrasound Thalamotomy in Parkinson’s Disease
Mood, cognitive, and behavioral changes in tremor-predominant Parkinson’s disease patients, three and 12 months after receiving MRI-guided focused ultrasound thalamotomy, were correlated with quality of life more than the severity of tremor reduction.
-
Effect of Diet on Hippocampal Volume in a Population at Risk for Alzheimer’s Disease
Magnetic resonance imaging of the brain in community-dwelling people (average age of 60 years) found that a long-term, high-quality diet was associated with larger hippocampal volumes after an average interval of 11 years.
-
Is it Guillain-Barré or Acute-onset CIDP?
Acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy (CIDP) may present with identical clinical pictures and can be differentiated only with the passage of time. CIDP will have a slower course of progression and may involve relapses.
-
Recent Advances in Sleep Medicine
This article reviews recently published research on sleep medicine. -
Primary Headaches: Look, Listen, and Diagnose Rather Than Image
SYNOPSIS: The diagnosis of primary headache disorders by a computerized and clinical paradigm can predict a baseline prevalence of intracranial abnormalities on brain imaging. Some historical “red flags” in children with headaches, including morning headaches and occipital pain, are not associated with increased intracranial abnormalities.
-
Cerebellar Atrophy May Contribute to Cognitive Impairment in FTD
In this cross-sectional study, researchers identified distinct patterns of cerebellar atrophy and its association with cognitive dysfunction in the frontotemporal dementia syndromes.
-
Ibudilast Shows Promise for the Treatment of Progressive MS
A Phase II trial of ibudilast in progressive multiple sclerosis demonstrated a decreased rate of brain atrophy when compared to placebo.
-
Steroid Treatment Regimens for Chronic Inflammatory Demyelinating Polyneuropathy
In the United States, first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) is intravenous immunoglobulin (IVIG). Authors of this retrospective survey from Europe found that corticosteroid treatment had similar efficacy as IVIG and should be considered as first-line therapy for CIDP.
-
Dual Antiplatelet Therapy for Acute Ischemic Stroke and TIA